Effectiveness of treatment of newly diagnosed hypertension in family medicine practices in South Croatia.
Arterial hypertension
Blood pressure
Control
Hypertension treatment
Island
Normotension
Rural
Urban
Journal
BMC family practice
ISSN: 1471-2296
Titre abrégé: BMC Fam Pract
Pays: England
ID NLM: 100967792
Informations de publication
Date de publication:
14 01 2019
14 01 2019
Historique:
received:
15
07
2018
accepted:
02
01
2019
entrez:
16
1
2019
pubmed:
16
1
2019
medline:
11
2
2020
Statut:
epublish
Résumé
Uncontrolled blood pressure remains an urgent issue in clinical practice worldwide. This study aimed to compare the characteristics and effectiveness of hypertension control in family medicine pratice in the first treatment year, in relation to the geographical position, socio-economic standard, and access to medical services and public pharmacies in urban, rural and island environments (city of Split vs. Dalmatian Hinterland vs. islands in Southern Croatia). A historical cohort study included 213 patients diagnosed from 2008 to 2014 with essential arterial hypertension (AH) and without related complications or diabetes mellitus. Each patient was followed up for 365 days from the visit when the diagnosis of hypertension was ascertained. Normotension was defined as arterial pressure < 140/90 mmHg. The annual cost of drugs prescribed for treating newly diagnosed hypertensive patient and the total price for defined daily dose per patient were also evaluated. More than half patients achieved normotension within a year from the initial diagnosis in all family medicine practices (57.3%), without significant differences among the three geographic regions (P = 0.981). Higher initial systolic blood pressure was a positive predictive prognostic factor on achieveing normotension (odds ratio (OR) 0.96, 95% confidence interval 0.95-0.98). ACE inhibitors were the most commonly prescribed antihypertensive agents in monotherapy (35.1%), as well as considering overall prescriptions (25.2%). Calcium channel blockers were the most commonly prescribed initial BP-lowering single agents in urban areas (28.6%), whereas angiotensin-converting enzyme inhibitors were more common in rural (28.0%) and island areas (22.7%) (P = 0.037). The median annual antihypertensive drug cost was 169.4 (95% CI 151.5-201.8) Croatian kunas and was similar across the study sites. Multiple antihypertensive drugs, prescribed in accordance with the guidelines, lead to similar pharmacological effects. Primary care physicians seem to be able to overcome potential interfering socio-economic factors and successfully achieve normotension in newly diagnosed patients with uncomplicated AH after 1 year of treatment.
Sections du résumé
BACKGROUND
Uncontrolled blood pressure remains an urgent issue in clinical practice worldwide. This study aimed to compare the characteristics and effectiveness of hypertension control in family medicine pratice in the first treatment year, in relation to the geographical position, socio-economic standard, and access to medical services and public pharmacies in urban, rural and island environments (city of Split vs. Dalmatian Hinterland vs. islands in Southern Croatia).
METHODS
A historical cohort study included 213 patients diagnosed from 2008 to 2014 with essential arterial hypertension (AH) and without related complications or diabetes mellitus. Each patient was followed up for 365 days from the visit when the diagnosis of hypertension was ascertained. Normotension was defined as arterial pressure < 140/90 mmHg. The annual cost of drugs prescribed for treating newly diagnosed hypertensive patient and the total price for defined daily dose per patient were also evaluated.
RESULTS
More than half patients achieved normotension within a year from the initial diagnosis in all family medicine practices (57.3%), without significant differences among the three geographic regions (P = 0.981). Higher initial systolic blood pressure was a positive predictive prognostic factor on achieveing normotension (odds ratio (OR) 0.96, 95% confidence interval 0.95-0.98). ACE inhibitors were the most commonly prescribed antihypertensive agents in monotherapy (35.1%), as well as considering overall prescriptions (25.2%). Calcium channel blockers were the most commonly prescribed initial BP-lowering single agents in urban areas (28.6%), whereas angiotensin-converting enzyme inhibitors were more common in rural (28.0%) and island areas (22.7%) (P = 0.037). The median annual antihypertensive drug cost was 169.4 (95% CI 151.5-201.8) Croatian kunas and was similar across the study sites.
CONCLUSION
Multiple antihypertensive drugs, prescribed in accordance with the guidelines, lead to similar pharmacological effects. Primary care physicians seem to be able to overcome potential interfering socio-economic factors and successfully achieve normotension in newly diagnosed patients with uncomplicated AH after 1 year of treatment.
Identifiants
pubmed: 30642264
doi: 10.1186/s12875-019-0902-2
pii: 10.1186/s12875-019-0902-2
pmc: PMC6330736
doi:
Substances chimiques
Angiotensin-Converting Enzyme Inhibitors
0
Antihypertensive Agents
0
Calcium Channel Blockers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10Références
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
J Clin Hypertens (Greenwich). 2016 Jun;18(6):551-6
pubmed: 26459236
Lancet. 2002 Mar 23;359(9311):995-1003
pubmed: 11937178
J Hypertens. 2008 Dec;26(12):2303-11
pubmed: 19008709
Int J Hypertens. 2015;2015:975819
pubmed: 26171244
Acta Med Croatica. 2007 Jun;61(3):287-92
pubmed: 17629104
JAMA. 2003 May 21;289(19):2560-72
pubmed: 12748199
PLoS One. 2016 Jan 19;11(1):e0146181
pubmed: 26784948
NCHS Data Brief. 2015 Nov;(220):1-8
pubmed: 26633197
J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
pubmed: 12461301
J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26
pubmed: 24341872
Circulation. 2001 Dec 4;104(23):2855-64
pubmed: 11733407
Croat Med J. 2004 Oct;45(5):543-9
pubmed: 15495277
JAMA. 2004 Apr 21;291(15):1850-6
pubmed: 15100203
Hypertension. 2001 Apr;37(4):1053-9
pubmed: 11304502
Medicine (Baltimore). 2015 Dec;94(50):e1959
pubmed: 26683910
J Am Heart Assoc. 2012 Dec 31;2(1):e004531
pubmed: 23525411
Blood Press Suppl. 2005 Dec;2:33-41
pubmed: 16429641
Am J Med. 2009 Mar;122(3):290-300
pubmed: 19272490
J Hypertens. 2017 Jul;35(7):1465-1473
pubmed: 28319592
Can J Cardiol. 2015 May;31(5):664-70
pubmed: 25936492
Rev Med Suisse. 2010 May 19;6(249):1011-2, 1014-5
pubmed: 20568366
J Hum Hypertens. 2016 Apr;30(4):237-44
pubmed: 26310186
Wien Klin Wochenschr. 2013 Apr;125(7-8):173-9
pubmed: 23508873
Eur J Health Econ. 2008 Aug;9(3):229-36
pubmed: 17566802
Health Syst Transit. 2014;16(3):xvii-xviii, 1-162
pubmed: 25115139
J Hypertens. 2003 Nov;21(11):1983-92
pubmed: 14597836
Aust Fam Physician. 2010 Jul;39(7):511-6
pubmed: 20628667
Arch Cardiovasc Dis. 2009 Jun-Jul;102(6-7):477-83
pubmed: 19664567
Value Health Reg Issues. 2017 Sep;13:27-30
pubmed: 29073984
J Hypertens. 2013 Jul;31(7):1281-357
pubmed: 23817082
J Clin Hypertens (Greenwich). 2012 Oct;14(10):680-5
pubmed: 23031145
Hypertension. 2012 Oct;60(4):898-905
pubmed: 22949530
J Public Health (Oxf). 2016 Sep;38(3):450-458
pubmed: 25922371
Cardiovasc Diabetol. 2009 Mar 27;8:18
pubmed: 19327149
Hypertension. 2010 Feb;55(2):399-407
pubmed: 20026768
Croat Med J. 2011 Aug 15;52(4):566-75
pubmed: 21853552
Int J Public Health. 2015 May;60(4):417-26
pubmed: 25732703
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Swiss Med Wkly. 2012 Oct 30;142:w13693
pubmed: 23136051
Blood Press. 2017 Feb;26(1):39-47
pubmed: 27195533
Acta Pol Pharm. 2014 Jan-Feb;71(1):197-203
pubmed: 24779208
Rev Epidemiol Sante Publique. 2017 Aug;65(4):277-284
pubmed: 28410864
Int J Clin Pharmacol Ther. 2012 Jul;50(7):483-9
pubmed: 22578201
Can Fam Physician. 2018 Nov;64(11):832-840
pubmed: 30429181
J Hum Hypertens. 2006 Nov;20(11):874-81
pubmed: 16929341
N Engl J Med. 2000 Mar 30;342(13):905-12
pubmed: 10738048
Cardiovasc J Afr. 2016 Nov/Dec;27(6):361-366
pubmed: 27965999
Can J Cardiol. 2014 May;30(5 Suppl):S16-22
pubmed: 24750978
Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):572-8
pubmed: 26979767
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53
pubmed: 16257341
J Hypertens. 2016 Jan;34(1):39-46
pubmed: 26630211
Hypertension. 2014 Apr;63(4):878-85
pubmed: 24243703
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
PLoS One. 2015 Oct 13;10(10):e0140021
pubmed: 26461923
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Apr;37(4):469-74
pubmed: 27087208
Indian J Public Health. 2016 Jan-Mar;60(1):17-25
pubmed: 26911213
J Med Liban. 2015 Apr-Jun;63(2):74-80
pubmed: 26164975